Price T Rowe Associates Inc. MD Trims Stake in C4 Therapeutics, Inc. (NASDAQ:CCCC)
Price T Rowe Associates Inc. MD lessened its holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 90.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 38,143 shares of the company’s stock after selling 353,861 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in C4 Therapeutics were worth $138,000 […]
Price T Rowe Associates Inc. MD lessened its holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 90.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 38,143 shares of the company’s stock after selling 353,861 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in C4 Therapeutics were worth $138,000 […]
